Skip to main
AHR

AHR Stock Forecast & Price Target

AHR Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 27%
Buy 73%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

American Healthcare REIT is well-positioned for future growth, with a strong and diversified portfolio of healthcare-related properties, particularly in the senior housing and outpatient medical sectors. The company has a solid pipeline of potential investments and its focus on integrated senior health campuses has shown positive operating momentum. Furthermore, the recent equity issuance has strengthened the company's balance sheet, providing ample liquidity for future investments. While there are risks related to the healthcare operating environment and the performance of its largest tenant, Trilogy, we believe the company's strong portfolio and solid management team make it a compelling investment opportunity.

Bears say

American Healthcare REIT is facing some challenges as it continues to rely heavily on its Integrated Senior Health Campuses segment for the majority of its revenue. However, with increasing competition and a moderate growth outlook, this reliance may result in stagnation in future earnings. Additionally, the REIT's high level of debt and focus on equity funding for future investments pose potential risks for the company's financial health. Finally, the company's lack of a comprehensive sustainability strategy and dependence on one operator for over half of its NOI may also be detrimental in the long run.

AHR has been analyzed by 11 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 73% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of American Healthcare REIT Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About American Healthcare REIT Inc (AHR) Forecast

Analysts have given AHR a Buy based on their latest research and market trends.

According to 11 analysts, AHR has a Buy consensus rating as of Jun 26, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $54, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $54, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

American Healthcare REIT Inc (AHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.